Project Grant R21AI190325
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore $678,218 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a five-year Project Grant beginning April 1, 2026 and concluding March 31, 2031. This research initiative delivers multi-omics scientific analysis and investigative services focused on bacteria-host interactions in Brugia malayi, a medically important parasitic nematode...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore $445,488 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period from July 1, 2025 through June 30, 2027. This Project Grant supports scientific research to characterize long non-coding RNAs (lncRNAs) in Plasmodium falciparum and elucidate their roles in gene regulation. The research deliverables include...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded University of Maryland, Baltimore a $463,676 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 7, 2025, with completion targeted for July 31, 2030. This research initiative will generate scientific knowledge and methodological advances focused on understanding Fc-mediated effector functions in infectious disease contexts, specifically...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $777,360 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This award funds research titled "Advancing Lymphatic Filariasis Elimination with Parasite Genomic Epidemiology," which will deliver comprehensive genomic analysis and characterization of Wuchereria bancrofti...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, College Park $193,733 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated biomedical research addressing drug resistance mechanisms in cutaneous leishmaniasis. The project, which commenced September 24, 2025 and concludes August 31, 2027, focuses on examining the role of tryptophan catabolism and aryl...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore a $455,500 Project Grant on February 3, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports a two-year research initiative (completion date: January 31, 2028) investigating the functional heterogeneity of gamma-delta (VD2) T cells in cord blood and neonatal populations. The research aims to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore $136,988 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 20, 2025, with a completion date of July 31, 2027. This Project Grant supports investigator-initiated biomedical research aimed at advancing scientific understanding of infectious disease mechanisms and developing therapeutic strategies. The award funds research...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore a Project Grant totaling $281,480 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 12, 2025, with a completion date of August 31, 2030. This research grant funds a secondary analysis study examining the role of sex hormones and gender-affirming hormone therapy in anal human papillomavirus (HPV) persistence and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $849,146 to the University of Maryland, Baltimore on September 9, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports investigator-initiated research into the molecular mechanisms of anthrax toxin unfolding and translocation, with a project completion date of August 31, 2027. The research focuses on understanding how...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Massachusetts a $412,581 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2027. This research initiative focuses on investigating specialized mitochondrial deoxyribonucleic acid (DNA) polymerases in African trypanosomes to advance understanding of kinetoplast DNA (kDNA) replication mechanisms....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore a $440,211 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 16, 2026 through March 31, 2028. This research initiative focuses on investigating the epigenetic regulation of neo-sex chromosomes in filarial parasites, with the goal of generating fundamental biological knowledge that could inform the development of lineage-specific therapeutic interventions against filarial disease. The research directly examines filarial nematodes—obligate vertebrate parasites that represent a major cause of morbidity and mortality in tropical regions and are currently difficult to treat due to drug contraindications in co-endemic disease areas. The funded research will generate scientific knowledge regarding sex chromosome evolution and differentiation mechanisms specific to filarial nematodes, which possess unique neo-Y chromosomes not found in commonly studied model organisms such as Caenorhabditis elegans. The study will assess whether known mechanisms of sex chromosome regulation apply to these parasitic organisms and contribute to understanding of genome evolution more broadly. By developing enhanced understanding of filarial parasite biology and essential genetic traits, this research supports NIAID's mission to advance scientific knowledge and improve public health outcomes in addressing infectious disease challenges, particularly in resource-limited tropical settings where filarial infections represent significant disease burdens.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $440.2k | 4/16/26 |